v3.26.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Revenues
Operating costs:    
General and administrative expenses 8,773,329 4,712,753
Research and development expenses 1,719,783 3,305,575
Total operating costs 10,493,112 8,018,328
Other income (expense):    
Interest income 98,911 165,669
Other expense (13,072)
Unrealized loss on short-term investment (35,212)
Total other income, net 50,627 165,669
Net Loss (10,442,485) (7,852,659)
Deemed dividend (21,556,821)
Net loss attributable to common stockholders $ (31,999,306) $ (7,852,659)
Basic loss per share $ (1.35) $ (0.51)
Diluted loss per share $ (1.35) $ (0.51)
Basic weighted average common stock shares outstanding 23,694,333 15,444,149